Advanced search

Vol 92, No 11 (2021)
Guidelines / Expert consensus
Published online: 2021-11-10

open access

View PDF Download PDF file
Page views 7175
Article views/downloads 1225
Get Citation

Connect on Social Media

Connect on Social Media

Urogynecology Section of the Polish Society of Gynecologists and Obstetricians guidelines on the management of stress urinary incontinence in women

Klaudia Stangel-Wojcikiewicz1, Artur Rogowski23, Tomasz Rechberger4, Wlodzimierz Baranowski5, Magdalena E. Grzybowska6, Tomasz Kluz7, Elzbieta Narojczyk-Swiesciak8, Edyta Wlazlak9, Bartlomiej Burzynski10, Grzegorz Surkont9
DOI: 10.5603/GP.a2021.0206
Pubmed: 34907521
Ginekol Pol 2021;92(11):822-828.

Abstract

Objectives: The aim was to present an interdisciplinary Guideline of the Urogynecology Section of the Polish Society of Gynecologists and Obstetricians (PSGO) for the management of stress urinary incontinence (SUI).
Material and methods: A review of the literature, including current international guidelines and earlier recommendations of the PSGO Urogynecology Section, about the treatment of SUI was conducted.
Results: Management of SUI is presented. Four lines of therapy were identified: line 1 — the so-called ‘conservative treatment’, which should always be attempted, regardless of SUI symptom severity; line 2 — surgical intervention; lines 3 and 4 — reoperations after unsuccessful surgeries from line 2. The literature reports which provided supporting evidence for this Guideline, including the practical aspects, were discussed.
Conclusions: A systematic review of the guidelines and an analysis of SUI management were conducted. The need for an individualized approach was emphasized.

Keywords: urinary incontinencestress urinary incontinenceconservative treatmentphysiotherapysurgical treatmentmidurethral slingcolposuspension

Article available in PDF format

View PDF Download PDF file

References

  1. Haylen BT, de Ridder D, Freeman RM, et al. International Urogynecological Association, International Continence Society. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010; 29(1): 4–20.
    CrossRefPubMed
  2. Wlaźlak E, Surkont G, Shek KaL, et al. Can we predict urinary stress incontinence by using demographic, clinical, imaging and urodynamic data? Eur J Obstet Gynecol Reprod Biol. 2015; 193: 114–117.
    CrossRefPubMed
  3. Bettez M, Tu LeM, Carlson K, et al. 2012 update: guidelines for adult urinary incontinence collaborative consensus document for the canadian urological association. Can Urol Assoc J. 2012; 6(5): 354–363.
    CrossRefPubMed
  4. Nambiar AK, Bosch R, Cruz F, et al. Asociación Europea de Urología, European Association of Urology. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol. 2012; 62(6): 1130–1142.
    CrossRefPubMed
  5. Fabian G, Kociszewski J, Kuszka A, et al. Vaginal excision of the sub-urethral sling: analysis of indications, safety and outcome. Arch Med Sci. 2015; 11(5): 982–982.
    CrossRefPubMed
  6. Giarenis I, Mastoroudes H, Cardozo L, et al. What do we do when a midurethral tape fails? Rediscovery of open colposuspension as a salvage continence operation. International Urogynecology Journal. 2012; 23(8): 1117–1122.
    CrossRef
  7. Surkont G, Wlaźlak E, Petri E, et al. Standardized modified colposuspension--mid-term results of prospective studies in one centre. Ann Agric Environ Med. 2015; 22(2): 293–296.
    CrossRefPubMed
  8. Wein AJ. Committee Opinion No. 603: Evaluation of uncomplicated stress urinary incontinence in women before surgical treatment. Obstet Gynecol. 2014; 123(6): 1403–1407.
    CrossRefPubMed
  9. Teunissen TAM, Lagro-Janssen ALM. Sex differences in the use of absorbent (incontinence) pads in independently living elderly people: do men receive less care? Int J Clin Pract. 2009; 63(6): 869–873.
    CrossRefPubMed
  10. Sarma AV, Kanaya A, Nyberg LM, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study. Urology. 2009; 73(6): 1203–1209.
    CrossRefPubMed
  11. Bryant CM, Dowell CJ, Fairbrother G. Caffeine reduction education to improve urinary symptoms. Br J Nurs. 2002; 11(8): 560–565.
    CrossRefPubMed
  12. Fuselier A, Hanberry J, Margaret Lovin J, et al. Obesity and stress urinary incontinence: impact on pathophysiology and treatment. Curr Urol Rep. 2018; 19(1): 10.
    CrossRefPubMed
  13. National Collaborating Centre for Women's and Children's Health (UK). Urinary Incontinence in Women: The Management of Urinary Incontinence in Women. London: Royal College of Obstetricians and Gynecologists (UK); 2013.
  14. Nambiar AK, Bosch R, Cruz F, et al. Asociación Europea de Urología, European Association of Urology. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol. 2012; 62(6): 1130–1142.
    CrossRefPubMed
  15. Whitcomb EL, Subak LL. Effect of weight loss on urinary incontinence in women. Open Access J Urol. 2011; 3: 123–132.
    CrossRefPubMed
  16. Kaplan SA, Dmochowski R, Cash BD, et al. Systematic review of the relationship between bladder and bowel function: implications for patient management. Int J Clin Pract. 2013; 67(3): 205–216.
    CrossRefPubMed
  17. Carvalhais A, Natal Jorge R, Bø K. Performing high-level sport is strongly associated with urinary incontinence in elite athletes: a comparative study of 372 elite female athletes and 372 controls. Br J Sports Med. 2018; 52(24): 1586–1590.
    CrossRefPubMed
  18. Nygaard IE. Does prolonged high-impact activity contribute to later urinary incontinence? A retrospective cohort study of female Olympians. Obstet Gynecol. 1997; 90(5): 718–722.
    CrossRefPubMed
  19. Hannestad YS, Rortveit G, Daltveit AK, et al. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG. 2003; 110(3): 247–254.
    PubMed
  20. Fantl JA, Wyman JF, Harkins SW, et al. Bladder training in the management of lower urinary tract dysfunction in women. A review. J Am Geriatr Soc. 1990; 38(3): 329–332.
    CrossRefPubMed
  21. Marques A, Stothers L, Macnab A. The status of pelvic floor muscle training for women. Can Urol Assoc J. 2010; 4(6): 419–424.
    CrossRefPubMed
  22. Dumoulin C, Cacciari LP, Hay-Smith EJ. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018; 10: CD005654.
    CrossRefPubMed
  23. Cundiff GW, Weidner AC, Visco AG, et al. A survey of pessary use by members of the American urogynecologic society. Obstet Gynecol. 2000; 95(6 Pt 1): 931–935.
    CrossRefPubMed
  24. Donnelly MJ, Powell-Morgan S, Olsen AL, et al. Vaginal pessaries for the management of stress and mixed urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2004; 15(5): 302–307.
    CrossRefPubMed
  25. Wlaźlak E, Krzycka M, Surkont G. Wysiłkowe nietrzymanie moczu-leczenie zachowawcze, pessaroterapia. In: Baranowski, W, Rogowski A. ed. Uroginekologia. Medical Tribune : 254–265.
  26. Maund E, Guski LS, Gøtzsche PC. Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports. CMAJ. 2017; 189(5): E194–E203.
    CrossRefPubMed
  27. Historical information on duloxetine hydrochloride (marketed as Cymbalta). Silver Spring (MD): Food and Drug Administration (US); 2013. www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm114970htm (2016 May 30).
  28. Cody JD, Jacobs ML, Richardson K, et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012; 10: CD001405.
    CrossRefPubMed
  29. Robinson D, Cardozo L. Estrogens and the lower urinary tract. Neurourol Urodyn. 2011; 30(5): 754–757.
    CrossRefPubMed
  30. Donders GGG, Ruban K, Bellen G, et al. Pharmacotherapy for the treatment of vaginal atrophy. Expert Opin Pharmacother. 2019; 20(7): 821–835.
    CrossRefPubMed
  31. Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA. 2005; 293(8): 935–948.
    CrossRefPubMed
  32. Lemos N, Korte JE, Iskander M, et al. Center-by-center results of a multicenter prospective trial to determine the inter-observer correlation of the simplified POP-Q in describing pelvic organ prolapse. Int Urogynecol J. 2012; 23(5): 579–584.
    CrossRefPubMed
  33. Kluz T, Wlaźlak E, Surkont G. Transvaginal six-arm mesh OPUR in women with apical pelvic organ prolapse - analysis of short-term results, pelvic floor ultrasound evaluation. Ginekol Pol. 2017; 88(6): 302–306.
    CrossRefPubMed
  34. Amid PK. Classification of biomaterials and their related complications in abdominal wall hernia surgery. Hernia. 1997; 1(1): 15–21.
    CrossRef
  35. Klinge U, Klosterhalfen B. Modified classification of surgical meshes for hernia repair based on the analyses of 1,000 explanted meshes. Hernia. 2012; 16(3): 251–258.
    CrossRefPubMed
  36. Surkont G, Wlaźlak E, Suzin J. Long-term risk of complications after mid-urethral sling IVS implantation. Ann Agric Environ Med. 2015; 22(1): 163–166.
    CrossRefPubMed
  37. Kowalik CG, Dmochowski RR, De EJB. Surgery for female SUI: The ICI algorithm. Neurourol Urodyn. 2019; 38 Suppl 4: S21–S27.
    CrossRefPubMed
  38. Delorme E. [Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women]. Prog Urol. 2001; 11(6): 1306–1313.
  39. Wlaźlak E, Viereck V, Kociszewski J, et al. Role of intrinsic sphincter deficiency with and without urethral hypomobility on the outcome of tape insertion. Neurourol Urodyn. 2017; 36(7): 1910–1916.
    CrossRefPubMed
  40. Wlaźlak E, Kluz T, Kociszewski J, et al. The analysis of repeatability and reproducibility of bladder neck mobility measurements obtained during pelvic floor sonography performed introitally with 2D transvaginal probe. Ginekol Pol. 2017; 88(7): 360–365.
    CrossRefPubMed
  41. Wlaźlak E, Kluz T, Surkont G, et al. Urethral funneling visualized during pelvic floor sonography - analysis of occurrence among urogynecological patients. Ginekol Pol. 2018; 89(2): 55–61.
    CrossRefPubMed
  42. Kuszka A, Rautenberg O, Wlaźlak E, et al. Do different vaginal tapes need different suburethral incisions? The one-half rule. Neurourol Urodyn. 2015; 34(8): 741–746.
  43. Kociszewski J, Rautenberg O, Kuszka A, et al. Can we place tension-free vaginal tape where it should be? The one-third rule. Ultrasound Obstet Gynecol. 2012; 39(2): 210–214.
  44. Surkont G, Wlaźlak E, Dunicz-Sokolowska A, et al. [The efficacy of SUI treatment with Burch colposuspension evaluated with use of ITT analysis]. Ginekol Pol. 2007; 78(5): 378–380.
    PubMed
  45. Oliveira LM, Dias MM, Martins SB, et al. Surgical treatment for stress urinary incontinence in women: A systematic review and meta-analysis. Rev Bras Ginecol Obstet. 2018; 40(8): 477–490.
    CrossRefPubMed
  46. Asıcıoglu O, Gungorduk K, Besımoglu B, et al. A 5-year follow-up study comparing Burch colposuspension and transobturator tape for the surgical treatment of stress urinary incontinence. Int J Gynaecol Obstet. 2014; 125(1): 73–77.
    CrossRefPubMed
  47. Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017; 7: CD006375.
    CrossRefPubMed
  48. Kuhn A, Stadlmayr W, Lengsfeld D, et al. Where should bulking agents for female urodynamic stress incontinence be injected? Int Urogynecol J Pelvic Floor Dysfunct. 2008; 19(6): 817–821.
    CrossRefPubMed
  49. Hegde A, Smith AL, Aguilar VC, et al. Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent. Int Urogynecol J. 2013; 24(7): 1151–1159.
    CrossRefPubMed
  50. Leone Roberti Maggiore U, Bogani G, Meschia M, et al. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2015; 189: 48–54.
    CrossRefPubMed
  51. Mahdy A, Ghoniem GM. Autologous rectus fascia sling for treatment of stress urinary incontinence in women: A review of the literature. Neurourol Urodyn. 2019; 38 Suppl 4: S51–S58.
    CrossRefPubMed
  52. Alonso Ro, Fes As, Fernandez Barranco L, et al. Four-year experience with the flowsecure artificial urinary sphincter. Problems and solution. Neurol Urodyn. 2011; 30: 250.
  53. Stangel-Wojcikiewicz K, Piwowar M, Jach R, et al. Quality of life assessment in female patients 2 and 4 years after muscle-derived cell transplants for stress urinary incontinence treatment. Ginekol Pol. 2016; 87(3): 183–189.
    CrossRefPubMed
  54. Stangel-Wojcikiewicz K, Jarocha D, Piwowar M, et al. Autologous muscle-derived cells for the treatment of female stress urinary incontinence: A 2-year follow-up of a polish investigation. Neurourology and Urodynamics. 2013; 33(3): 324–330.
    CrossRefPubMed
  55. Stangel-Wójcikiewicz K. egenerative Medicine for the Treatment of Urinary Incontinence. Jagiellonian University Press .
  56. Peters KM, Dmochowski RR, Carr LK, et al. Autologous muscle derived cells for treatment of stress urinary incontinence in women. J Urol. 2014; 192(2): 469–476.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023-2024 Via Medica Regulations Cookie policy Privacy Statement Legal Note